deferoxamine
英 [dɪfərɒk'sæmi:n] 美 [dɪfərɒk'sæmin]

释义

去铁敏；

权威例句

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage.
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions.
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after...
Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional H...
A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardi...